Literature DB >> 27758885

Alternative Polyadenylation in Triple-Negative Breast Tumors Allows NRAS and c-JUN to Bypass PUMILIO Posttranscriptional Regulation.

Wayne O Miles1,2, Antonio Lembo3,4, Angela Volorio5, Elena Brachtel5, Bin Tian6, Dennis Sgroi5, Paolo Provero3,4, Nicholas Dyson1.   

Abstract

Alternative polyadenylation (APA) is a process that changes the posttranscriptional regulation and translation potential of mRNAs via addition or deletion of 3' untranslated region (3' UTR) sequences. To identify posttranscriptional-regulatory events affected by APA in breast tumors, tumor datasets were analyzed for recurrent APA events. Motif mapping of the changed 3' UTR regions found that APA-mediated removal of Pumilio regulatory elements (PRE) was unusually common. Breast tumor subtype-specific APA profiling identified triple-negative breast tumors as having the highest levels of APA. To determine the frequency of these events, an independent cohort of triple-negative breast tumors and normal breast tissue was analyzed for APA. APA-mediated shortening of NRAS and c-JUN was seen frequently, and this correlated with changes in the expression of downstream targets. mRNA stability and luciferase assays demonstrated APA-dependent alterations in RNA and protein levels of affected candidate genes. Examination of clinical parameters of these tumors found those with APA of NRAS and c-JUN to be smaller and less proliferative, but more invasive than non-APA tumors. RT-PCR profiling identified elevated levels of polyadenylation factor CSTF3 in tumors with APA. Overexpression of CSTF3 was common in triple-negative breast cancer cell lines, and elevated CSTF3 levels were sufficient to induce APA of NRAS and c-JUN. Our results support the hypothesis that PRE-containing mRNAs are disproportionately affected by APA, primarily due to high sequence similarity in the motifs utilized by polyadenylation machinery and the PUM complex. Cancer Res; 76(24); 7231-41. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27758885      PMCID: PMC5553310          DOI: 10.1158/0008-5472.CAN-16-0844

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

1.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.

Authors:  Brian D Lehmann; Joshua A Bauer; Xi Chen; Melinda E Sanders; A Bapsi Chakravarthy; Yu Shyr; Jennifer A Pietenpol
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  The Caenorhabditis elegans pumilio homolog, puf-9, is required for the 3'UTR-mediated repression of the let-7 microRNA target gene, hbl-1.

Authors:  Mona J Nolde; Nazli Saka; Kristy L Reinert; Frank J Slack
Journal:  Dev Biol       Date:  2007-03-03       Impact factor: 3.582

3.  Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites.

Authors:  Rickard Sandberg; Joel R Neilson; Arup Sarma; Phillip A Sharp; Christopher B Burge
Journal:  Science       Date:  2008-06-20       Impact factor: 47.728

4.  Differential genome-wide profiling of tandem 3' UTRs among human breast cancer and normal cells by high-throughput sequencing.

Authors:  Yonggui Fu; Yu Sun; Yuxin Li; Jie Li; Xingqiang Rao; Chong Chen; Anlong Xu
Journal:  Genome Res       Date:  2011-04-07       Impact factor: 9.043

5.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

6.  Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.

Authors:  François Bertucci; Pascal Finetti; Jacques Rougemont; Emmanuelle Charafe-Jauffret; Nathalie Cervera; Carole Tarpin; Catherine Nguyen; Luc Xerri; Rémi Houlgatte; Jocelyne Jacquemier; Patrice Viens; Daniel Birnbaum
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

7.  A large-scale analysis of mRNA polyadenylation of human and mouse genes.

Authors:  Bin Tian; Jun Hu; Haibo Zhang; Carol S Lutz
Journal:  Nucleic Acids Res       Date:  2005-01-12       Impact factor: 16.971

8.  Dissecting the expression landscape of RNA-binding proteins in human cancers.

Authors:  Bobak Kechavarzi; Sarath Chandra Janga
Journal:  Genome Biol       Date:  2014-01-10       Impact factor: 13.583

9.  Dynamic landscape of tandem 3' UTRs during zebrafish development.

Authors:  Yuxin Li; Yu Sun; Yonggui Fu; Mengzhen Li; Guangrui Huang; Chenxu Zhang; Jiahui Liang; Shengfeng Huang; Gaoyang Shen; Shaochun Yuan; Liangfu Chen; Shangwu Chen; Anlong Xu
Journal:  Genome Res       Date:  2012-09-05       Impact factor: 9.043

10.  The nucleosome regulates the usage of polyadenylation sites in the human genome.

Authors:  Huan Huang; Jiao Chen; Hongde Liu; Xiao Sun
Journal:  BMC Genomics       Date:  2013-12-23       Impact factor: 3.969

View more
  24 in total

Review 1.  The Untranslated Regions of mRNAs in Cancer.

Authors:  Samantha L Schuster; Andrew C Hsieh
Journal:  Trends Cancer       Date:  2019-03-22

Review 2.  RNA-biology ruling cancer progression? Focus on 3'UTRs and splicing.

Authors:  Ayse Elif Erson-Bensan
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 3.  Functions, mechanisms and regulation of Pumilio/Puf family RNA binding proteins: a comprehensive review.

Authors:  M J Nishanth; Bindu Simon
Journal:  Mol Biol Rep       Date:  2019-10-23       Impact factor: 2.316

4.  NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.

Authors:  Sheng Tan; Hua Li; Weijie Zhang; Yunying Shao; Yuan Liu; Haiyang Guan; Jun Wu; Yani Kang; Junsong Zhao; Qing Yu; Yunzhao Gu; Keshuo Ding; Min Zhang; Wenchang Qian; Yong Zhu; Huayong Cai; Changyu Chen; Peter E Lobie; Xiaodong Zhao; Jielin Sun; Tao Zhu
Journal:  Oncogene       Date:  2018-05-21       Impact factor: 9.867

5.  Alternative polyadenylation dysregulation contributes to the differentiation block of acute myeloid leukemia.

Authors:  Amanda G Davis; Daniel T Johnson; Dinghai Zheng; Ruijia Wang; Nathan D Jayne; Mengdan Liu; Jihae Shin; Luyang Wang; Samuel A Stoner; Jie-Hua Zhou; Edward D Ball; Bin Tian; Dong-Er Zhang
Journal:  Blood       Date:  2022-01-20       Impact factor: 25.476

Review 6.  Nanos genes and their role in development and beyond.

Authors:  Evi De Keuckelaere; Paco Hulpiau; Yvan Saeys; Geert Berx; Frans van Roy
Journal:  Cell Mol Life Sci       Date:  2018-02-03       Impact factor: 9.261

7.  Pumilio response and AU-rich elements drive rapid decay of Pnrc2-regulated cyclic gene transcripts.

Authors:  Kiel T Tietz; Thomas L Gallagher; Monica C Mannings; Zachary T Morrow; Nicolas L Derr; Sharon L Amacher
Journal:  Dev Biol       Date:  2020-04-01       Impact factor: 3.582

8.  Integrative 3' Untranslated Region-Based Model to Identify Patients with Low Risk of Axillary Lymph Node Metastasis in Operable Triple-Negative Breast Cancer.

Authors:  Lei Wang; Xin Hu; Peng Wang; Zhi-Ming Shao
Journal:  Oncologist       Date:  2018-08-06

9.  The structural basis of CstF-77 modulation of cleavage and polyadenylation through stimulation of CstF-64 activity.

Authors:  Petar N Grozdanov; Elahe Masoumzadeh; Michael P Latham; Clinton C MacDonald
Journal:  Nucleic Acids Res       Date:  2018-12-14       Impact factor: 16.971

Review 10.  Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer.

Authors:  Shakur Mohibi; Xinbin Chen; Jin Zhang
Journal:  Pharmacol Ther       Date:  2019-07-11       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.